ETR:BNR - Brenntag Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
€43.98 -0.06 (-0.14 %)
(As of 02/21/2019 04:00 PM ET)
Previous Close€44.04
Today's Range€43.93 - €44.35
52-Week RangeN/A
Volume255,745 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals. The company was founded in 1874 and is headquartered in Essen, Germany.

Receive BNR News and Ratings via Email

Sign-up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
CIKN/A
Phone49 201 6496 1141

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Brenntag (ETR:BNR) Frequently Asked Questions

What is Brenntag's stock symbol?

Brenntag trades on the ETR under the ticker symbol "BNR."

What price target have analysts set for BNR?

6 brokers have issued 1-year target prices for Brenntag's stock. Their forecasts range from €50.00 to €63.00. On average, they anticipate Brenntag's stock price to reach €57.80 in the next twelve months. This suggests a possible upside of 31.4% from the stock's current price. View Analyst Price Targets for Brenntag.

What is the consensus analysts' recommendation for Brenntag?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Brenntag in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Brenntag.

Has Brenntag been receiving favorable news coverage?

Media coverage about BNR stock has been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Brenntag earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next several days.

Who are some of Brenntag's key competitors?

What other stocks do shareholders of Brenntag own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Brenntag investors own include Quality Systems (QSII), Morgan Stanley (MS), Callon Petroleum (CPE), Zalando (ZAL), Radius Health (RDUS), Ascendant Resources (ASND), Agios Pharmaceuticals (AGIO), FMC (FMC), Teladoc Health (TDOC) and NuVasive (NUVA).

Who are Brenntag's key executives?

Brenntag's management team includes the folowing people:
  • Mr. Steven E. Holland, Chairman of Board of Management & CEO (Age 62)
  • Mr. Georg Müller, CFO & Member of Board of Management
  • Mr. Karsten Beckmann, Member of Board of Management and CEO of Europe, Middle East & Africa Region (Age 57)
  • Mr. Markus Klähn, Member of Board of Management, CEO & Pres of North America (Age 51)
  • Mr. Henri Nejade, Member of Board of Management & CDO of Asia Pacific Region

What is Brenntag's stock price today?

One share of BNR stock can currently be purchased for approximately €43.98.

What is Brenntag's official website?

The official website for Brenntag is http://www.brenntag.com.

How can I contact Brenntag?

The company can be reached via phone at 49 201 6496 1141.


MarketBeat Community Rating for Brenntag (ETR BNR)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  55
MarketBeat's community ratings are surveys of what our community members think about Brenntag and other stocks. Vote "Outperform" if you believe BNR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BNR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel